0001736361-21-000001.txt : 20210507 0001736361-21-000001.hdr.sgml : 20210507 20210507155824 ACCESSION NUMBER: 0001736361-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210507 DATE AS OF CHANGE: 20210507 EFFECTIVENESS DATE: 20210507 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Acworth Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001736361 IRS NUMBER: 814610456 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-398646 FILM NUMBER: 21902438 BUSINESS ADDRESS: STREET 1: C/O LABCENTRAL STREET 2: 700 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-529-0160 MAIL ADDRESS: STREET 1: C/O LABCENTRAL STREET 2: 700 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0708 D LIVE 0001736361 Acworth Pharmaceuticals, Inc. C/O LABCENTRAL 700 MAIN STREET CAMBRIDGE MA MASSACHUSETTS 02139 617-529-0160 DELAWARE None None Corporation true 2016 Edward W. Marple c/o Lab Central 700 Main Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Promoter Travis Metz c/o Lab Central 700 Main Street Cambridge MA MASSACHUSETTS 02139 Director Jack Leonard c/o Lab Central 700 Main Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Promoter Biotechnology Decline to Disclose 06b false 2021-04-30 false true true true false 0 500000 352181 147819 false 14 0 0 0 true Proceeds will be used for working capital, which may include normal compensation to executive officers false Acworth Pharmaceuticals, Inc. Edward W. Marple Edward W. Marple CEO 2021-05-06